Strattera has been approved by the Food and Drug Administration to treat Attention Deficit Hyperactivity Disorder (ADHD) for children six years old to twelve years old. This medication has not been tested in children under the age of six and should not be given to children five and under.
Strattera is available in the following strengths:
Physicians will often start patients on lower...Read more
Our readers ask some great questions about Migraine disease and other headache disorders here on HealthCentral's Migraine community. Nancy... Read more »